Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 126 100 KRW -0.32% Market Closed
Market Cap: 1.5T KRW
Have any thoughts about
Daewoong Pharma?
Write Note

Daewoong Pharma
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daewoong Pharma
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Daewoong Pharma
KRX:069620
Selling, General & Administrative
-â‚©408B
CAGR 3-Years
-9%
CAGR 5-Years
-6%
CAGR 10-Years
-8%
Yuhan Corp
KRX:000100
Selling, General & Administrative
-â‚©394.7B
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
-7%
SK Biopharmaceuticals Co Ltd
KRX:326030
Selling, General & Administrative
-â‚©208.8B
CAGR 3-Years
-13%
CAGR 5-Years
-65%
CAGR 10-Years
N/A
Hanmi Science Co Ltd
KRX:008930
Selling, General & Administrative
-â‚©190B
CAGR 3-Years
-26%
CAGR 5-Years
-18%
CAGR 10-Years
-14%
Hanmi Pharm Co Ltd
KRX:128940
Selling, General & Administrative
-â‚©425.8B
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
-6%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Selling, General & Administrative
-â‚©83.7B
CAGR 3-Years
-9%
CAGR 5-Years
-5%
CAGR 10-Years
-7%
No Stocks Found

Daewoong Pharma
Glance View

Market Cap
1.5T KRW
Industry
Pharmaceuticals

Daewoong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2002-11-01. The firm's products mainly include antihypertensive drugs, antianemic agents, antidiabetic agents, antiemetic agents, antihistamine agents, antimicrobials, antineoplastics, antiobesity agents, antipyretic agents, analgesic agents, anti-inflammatory agents, biosimilars, remedies for bone and joint diseases, cardiovascular treatments, central nervous system treatments, digestive agents, dermatologic agents, gastrointestinal agents, health supplements and respiratory remedies, among others. The firm distributes its products in domestic and overseas markets.

Intrinsic Value
214 830.34 KRW
Undervaluation 41%
Intrinsic Value
Price

See Also

What is Daewoong Pharma's Selling, General & Administrative?
Selling, General & Administrative
-408B KRW

Based on the financial report for Sep 30, 2024, Daewoong Pharma's Selling, General & Administrative amounts to -408B KRW.

What is Daewoong Pharma's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-8%

Over the last year, the Selling, General & Administrative growth was -6%. The average annual Selling, General & Administrative growth rates for Daewoong Pharma have been -9% over the past three years , -6% over the past five years , and -8% over the past ten years .

Back to Top